Coats Group, a global leader in industrial threads and polymers, is aiming to expand its footprint despite facing ongoing challenges from market fluctuations and external economic pressures. The company, which holds approximately 20 percent of the worldwide market for industrial threads, reported mixed results over the past two years under the leadership of Chief Executive David Paja.

Since a recommendation two years ago, Coats’ share price has declined from 99p to below 80p, though shareholders have received a steady dividend yield of 4.8p. The company has grappled with customer destocking and trade disruptions caused by tariffs implemented by former U.S. President Donald Trump. Nonetheless, Coats delivered respectable financials, with adjusted revenue increasing by $30 million to $1.46 billion in the previous year. Operating profit rose by $18 million to $290 million, although earnings per share fell 5 percent to 9.3 cents.

In the first half of 2026, Coats reported further growth, with revenue rising 19 percent to $837 million and earnings before interest and tax (EBIT) increasing 19 percent to $166 million. However, like-for-like EBIT declined by 2 percent, and the organic margin decreased by 50 basis points to 19.3 percent. The overall margin remained stable, bolstered by the inclusion of OrthoLite, a newly acquired provider of high-performance footwear cushioning and sustainable foam products.

Paja, formerly of Melrose Industries, has adjusted Coats’ structure, consolidating its business divisions from three to two, focusing on performance materials divided 80-20 between clothing and footwear. Apparel accounted for $769 million in revenue last year, footwear for $440 million, and performance materials contributed $256 million. The company has exited the U.S. yarn market, citing intense competition, and closed a manufacturing site in Mexico.

The footwear segment is seen as a key growth area, with opportunities for innovation in lightweight, high-performance boots and shoes. Paja emphasized that half of Coats’ sales now come from footwear, which he describes as a polymer business rather than merely a thread company. OrthoLite experienced challenges related to tariffs and production issues in Indonesia but still contributed $28 million in EBIT on $123 million in sales during the first half of 2026, maintaining a 23 percent profit margin. To support growth, Coats is expanding capacity at its Indonesian factory with plans for further investment in the United Kingdom next year.

Synergies from the OrthoLite acquisition are anticipated to generate $5 million this year, increasing to $20 million by 2028. With the resolution of a long-standing UK pension liability, Coats expects a significant boost in free cash flow, enabling further expansion through acquisitions and share buybacks. Paja is pursuing what he terms "adjacencies" — product lines related to, but distinct from, traditional thread offerings, such as fibreglass tapes, woven materials, insoles, and protective tapes for fiber optics. These areas promise higher profit margins but remain in the early stages of contribution.

Investment analysts describe Coats as a value-oriented opportunity, with its price-earnings ratio trailing the UK industrial sector average and a dividend yield forecasted at approximately 3.5 percent. The company aims to achieve annual earnings per share growth of 10 percent. Analysts recommend a cautious “hold” position, noting that the full impact of Paja’s strategic initiatives will require additional time to materialize amid persistent market headwinds.